These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15110833)

  • 1. Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs.
    Zhang XW; Yap YL
    Bioorg Med Chem; 2004 May; 12(10):2517-21. PubMed ID: 15110833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach.
    Bello M
    J Mol Graph Model; 2020 Dec; 101():107762. PubMed ID: 33022569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors.
    Nukoolkarn V; Lee VS; Malaisree M; Aruksakulwong O; Hannongbua S
    J Theor Biol; 2008 Oct; 254(4):861-7. PubMed ID: 18706430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
    Chu CM; Cheng VC; Hung IF; Wong MM; Chan KH; Chan KS; Kao RY; Poon LL; Wong CL; Guan Y; Peiris JS; Yuen KY;
    Thorax; 2004 Mar; 59(3):252-6. PubMed ID: 14985565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design.
    Zhang XW; Yap YL
    Bioorg Med Chem; 2004 May; 12(9):2219-23. PubMed ID: 15080921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiretroviral drugs in severe acute respiratory syndrome].
    Yazdanpanah Y; Guéry B
    Presse Med; 2006 Jan; 35(1 Pt 2):105-7. PubMed ID: 16462674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sometimes intermediates. Do the job!
    Hilgenfeld R; Pumpor K
    Chem Biol; 2006 Mar; 13(3):235-6. PubMed ID: 16638527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.
    Liu Z; Huang C; Fan K; Wei P; Chen H; Liu S; Pei J; Shi L; Li B; Yang K; Liu Y; Lai L
    J Chem Inf Model; 2005; 45(1):10-17. PubMed ID: 15667124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease.
    Liu YC; Huang V; Chao TC; Hsiao CD; Lin A; Chang MF; Chow LP
    Biochem Biophys Res Commun; 2005 Jul; 333(1):194-9. PubMed ID: 15950190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus.
    Park JY; Jeong HJ; Kim JH; Kim YM; Park SJ; Kim D; Park KH; Lee WS; Ryu YB
    Biol Pharm Bull; 2012; 35(11):2036-42. PubMed ID: 22971649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments on coronavirus main protease/3C like protease inhibitors.
    Zhao Q; Weber E; Yang H
    Recent Pat Antiinfect Drug Discov; 2013 Aug; 8(2):150-6. PubMed ID: 23879823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
    Pillaiyar T; Manickam M; Namasivayam V; Hayashi Y; Jung SH
    J Med Chem; 2016 Jul; 59(14):6595-628. PubMed ID: 26878082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease.
    Paasche A; Zipper A; Schäfer S; Ziebuhr J; Schirmeister T; Engels B
    Biochemistry; 2014 Sep; 53(37):5930-46. PubMed ID: 25196915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Some Antiviral
    Hagar M; Ahmed HA; Aljohani G; Alhaddad OA
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
    Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
    J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design.
    Toney JH; Navas-Martín S; Weiss SR; Koeller A
    J Med Chem; 2004 Feb; 47(5):1079-80. PubMed ID: 14971887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS: pharmacotherapy.
    Tsang K; Zhong NS
    Respirology; 2003 Nov; 8 Suppl():S25-30. PubMed ID: 15018130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS.
    Vastag B
    JAMA; 2003 Oct; 290(13):1695-6. PubMed ID: 14519691
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Jung KH; Li JK; Chan PK; Sidwell RW
    Antiviral Res; 2008 Aug; 79(2):105-13. PubMed ID: 18423639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying inhibitors of the SARS coronavirus proteinase.
    Jenwitheesuk E; Samudrala R
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3989-92. PubMed ID: 14592491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.